How effective is Hydroxocobalamin for Pernicious Anaemia? (a real world drug study)
Summary:
Overall ratings: 3.8/5 Long term ratings: 4/5
This is a phase IV clinical study of how effective Hydroxocobalamin (hydroxocobalamin) is for Pernicious anaemia and for what kind of people. The study is created by eHealthMe from 4 Hydroxocobalamin users and is updated continuously.
What is Hydroxocobalamin?
Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.
What is Pernicious anaemia?
Pernicious anaemia (anaemia due to lack of vitamin b12) is found to be associated with 149 drugs and 303 conditions by eHealthMe. Check the latest studies of Pernicious anaemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4 people are studied for taking Hydroxocobalamin in Pernicious anaemia
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Hydroxocobalamin effectiveness for Pernicious anaemia (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 2
- high: 1
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 1
Gender of people who take Hydroxocobalamin for Pernicious anaemia *:
- female: 75 %
- male: 25 %
Age of people who take Hydroxocobalamin for Pernicious anaemia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 25 %
- 40-49: 25 %
- 50-59: 50 %
- 60+: 0.0 %
Who find Hydroxocobalamin more effective for Pernicious Anaemia?
Gender of people who take Hydroxocobalamin for Pernicious anaemia *:
- female: 50 %
- male: 50 %
Age of people who take Hydroxocobalamin for Pernicious anaemia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Hydroxocobalamin?
- You can start a phase IV clinical trial to monitor Hydroxocobalamin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Hydroxocobalamin (4,273 reports)
Treatments, associated drugs and conditions:
- Pernicious anaemia (1,494 reports)
How the study uses the data?
The study is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D vs. Atenolol, side effect and effectiveness comparison - now
- Sertraline and Nosebleed for Men aged 50-59 - 5 seconds ago
- Sertraline and Nose Bleed for Men aged 50-59 - 5 seconds ago
- Sertraline and Nose Bleeds for Men aged 50-59 - 5 seconds ago
- Sertraline and Epistaxis for Men aged 50-59 - 6 seconds ago
- Sertraline and Bleeding From The Nose for Men aged 50-59 - 6 seconds ago
- Sertraline and Nosebleeds for Men aged 50-59 - 6 seconds ago
- Rasuvo vs. Hydrocodone Bitartrate And Acetaminophen, side effect and effectiveness comparison - 30 seconds ago
- Hyoscyami Folium vs. Elavil, side effect and effectiveness comparison - 39 seconds ago
- Could Fluconazole cause Posterior Reversible Encephalopathy Syndrome? - 42 seconds ago